Your browser doesn't support javascript.
loading
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
Ilhan, Yusuf; Tatli, Ali Murat; Teker, Fatih; Onder, Arif Hakan; Kose, Fatih; Geredeli, Caglayan; Karaagac, Mustafa; Kaplan, Muhammet Ali; Inanc, Mevlude; Goktas Aydin, Sabin; Kargi, Aysegul; Arak, Haci; Ozturk, Banu; Besen, Ali Ayberk; Selvi, Oguzhan; Korkmaz, Mustafa; Oruc, Zeynep; Bozkurt, Oktay; Bilici, Ahmet; Bayram, Selami; Dae, Shute Ailia; Ozdogan, Mustafa; Coskun, Hasan Senol; Sezgin Goksu, Sema.
Afiliação
  • Ilhan Y; Department of Medical Oncology, Akdeniz University, Antalya, Turkey dryusufilhan@gmail.com.
  • Tatli AM; Department of Medical Oncology, Akdeniz University, Antalya, Turkey.
  • Teker F; Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey.
  • Onder AH; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Kose F; Department of Medical Oncology, Baskent Üniversitesi Adana Uygulama ve Arastirma Merkezi, Adana, Turkey.
  • Geredeli C; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Karaagac M; Department of Clinical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey.
  • Kaplan MA; Department of Medical Oncology, Dicle University, Diyarbakir, Turkey.
  • Inanc M; Department of Medical Oncology, Erciyes University, Kayseri, Turkey.
  • Goktas Aydin S; Department of Medical Oncology, Istanbul Medipol University, Istanbul, Turkey.
  • Kargi A; Department of Medical Oncology, Medstar Antalya Hospital, Antalya, Turkey.
  • Arak H; Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey.
  • Ozturk B; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Besen AA; Department of Medical Oncology, Baskent Üniversitesi Adana Uygulama ve Arastirma Merkezi, Adana, Turkey.
  • Selvi O; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Korkmaz M; Department of Clinical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey.
  • Oruc Z; Department of Medical Oncology, Dicle University, Diyarbakir, Turkey.
  • Bozkurt O; Department of Medical Oncology, Erciyes University, Kayseri, Turkey.
  • Bilici A; Department of Medical Oncology, Istanbul Medipol University, Istanbul, Turkey.
  • Bayram S; Department of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
  • Dae SA; Department of Medical Oncology, Baskent Üniversitesi Adana Uygulama ve Arastirma Merkezi, Adana, Turkey.
  • Ozdogan M; Department of Medical Oncology, Medstar Antalya Hospital, Antalya, Turkey.
  • Coskun HS; Department of Medical Oncology, Akdeniz University, Antalya, Turkey.
  • Sezgin Goksu S; Department of Medical Oncology, Akdeniz University, Antalya, Turkey.
Int J Gynecol Cancer ; 32(4): 502-507, 2022 04 04.
Article em En | MEDLINE | ID: mdl-35086927
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Cisplatino Tipo de estudo: Observational_studies Limite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Assunto da revista: GINECOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Cisplatino Tipo de estudo: Observational_studies Limite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Assunto da revista: GINECOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia